Quick-Med Technologies Inc. announced that Bernd Liesenfeld has been appointed as President of the company and as a member of its Board of Directors. Dr. Liesenfeld joined Quick-Med in 2004 and led the development of the NIMBUS(R) technology used in the Bioguard line of products licensed to Derma Sciences. He has been involved in all aspects of commercializing Quick-Med's antimicrobial technologies, including biochemistry, biosafety, regulatory and production development. Dr. Liesenfeld also led the Quick-Med team. Joining Dr. Liesenfeld on Quick-Med's leadership team will be Roy D. Carr as Vice President of Business Development, Dr. William Toreki as Vice President of Research & Development, and Nam H. Nguyen, Chief Financial Officer. Roy Carr joined Quick-Med in 2005 and has been serving as Director of Business Development since that time. Bill Toreki joined the Company in 2002 and is the lead inventor on seven of the Company's patents. He previously served as Quick-Med's Chief Scientist. Nam Nguyen, Chartered Global Management Accountant, has been CFO of Quick-Med since 2004. The company also announced that CEO Ladd Greeno and Vice-President of Research & Development Jerry Olderman would be stepping aside from their management roles in the company after a short transition period to be completed in mid-August. Both Mr. Greeno and Dr. Olderman will remain active with the company as members of its Board of Directors and as senior advisors. Mr. Greeno shall also remain as chairman of the Board.